The complexity of diagnosing rare disease: An organizing framework for outcomes research and health economics based on real-world evidence-Reference-Cited by-同舟云学术

The complexity of diagnosing rare disease: An organizing framework for outcomes research and health economics based on real-world evidence

Published:2021-12 Issue: Volume: Page:
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Hayeems Robin Z.,Michaels-Igbokwe Christine,Venkataramanan Viji,Hartley Taila,Acker Meryl,Gillespie Meredith,Ungar Wendy J.,Mendoza-Londona Roberto,Bernier Francois P.,Boycott Kym M.,Marshall Deborah A.

Funder

Canadian Institutes of Health Research

Genome Canada

Ontario Genomics Institute

Ontario Research Foundation

Genome British Columbia

Canada Research Chairs

Genome Alberta

Children's Hospital of Eastern Ontario Foundation

Publisher

Elsevier BV

Subject

Genetics (clinical)

Reference17 articles.

1. The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists;Boycott;J Med Genet,2015

2. Expanding use of clinical genome sequencing and the need for more data on implementation;Phillips;JAMA,2020

3. Being precise about precision medicine: what should value frameworks incorporate to address precision medicine? A report of the Personalized Precision Medicine Special Interest Group;Faulkner;Value Health,2020

4. Addressing challenges of economic evaluation in precision medicine using dynamic simulation modeling;Marshall;Value Health,2020

5. Valuation of health and nonhealth outcomes from next-generation sequencing: approaches, challenges, and solutions;Regier;Value Health,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uncovering the hidden socioeconomic impact of juvenile idiopathic arthritis and paving the way for other rare childhood diseases: an international, cross-disciplinary, patient-centered approach (PAVE Consortium);Pediatric Rheumatology;2024-08-09

2. Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies;PharmacoEconomics;2023-08-18

3. Protocol for a Prospective, Observational Cost-effectiveness Analysis of Returning Secondary Findings of Genome Sequencing for Unexplained Suspected Genetic Conditions;Clinical Therapeutics;2023-08

4. Developing a Framework of Cost Elements of Socioeconomic Burden of Rare Disease: A Scoping Review;PharmacoEconomics;2023-04-07

5. Real-world data: a brief review of the methods, applications, challenges and opportunities;BMC Medical Research Methodology;2022-11-05